Literature DB >> 18290995

Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment.

Shyam Sundar, Dinesh Mondal, Suman Rijal, Sujit Bhattacharya, Hashim Ghalib, Axel Kroeger, Marleen Boelaert, Philippe Desjeux, Heide Richter-Airijoki, Gundel Harms.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18290995     DOI: 10.1111/j.1365-3156.2007.01974.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


× No keyword cloud information.
  34 in total

1.  Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal.

Authors:  Siddhivinayak Hirve; Shri Prakash Singh; Narendra Kumar; Megha Raj Banjara; Pradeep Das; Shyam Sundar; Suman Rijal; Anand Joshi; Axel Kroeger; Beena Varghese; Chandreshwar Prasad Thakur; M Mamun Huda; Dinesh Mondal
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

2.  Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis.

Authors:  Medhavi Sudarshan; Jason L Weirather; Mary E Wilson; Shyam Sundar
Journal:  J Antimicrob Chemother       Date:  2011-05-24       Impact factor: 5.790

3.  Development of a reverse transcriptase loop-mediated isothermal amplification (LAMP) assay for the sensitive detection of Leishmania parasites in clinical samples.

Authors:  Emily R Adams; Gerard J Schoone; Al Farazdag Ageed; Sayda El Safi; Henk D F H Schallig
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

4.  A series of case reports of autochthonous visceral leishmaniasis, mostly in non-endemic hilly areas of Nepal.

Authors:  Sher Bahadur Pun; Kishor Pandey; Rajesh Shah
Journal:  Am J Trop Med Hyg       Date:  2012-12-18       Impact factor: 2.345

5.  Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum.

Authors:  S Hendrickx; G Boulet; A Mondelaers; J C Dujardin; S Rijal; L Lachaud; P Cos; P Delputte; L Maes
Journal:  Parasitol Res       Date:  2014-03-11       Impact factor: 2.289

Review 6.  Recent developments and future prospects in the treatment of visceral leishmaniasis.

Authors:  Shyam Sundar; Anup Singh
Journal:  Ther Adv Infect Dis       Date:  2016-04-22

Review 7.  Chemotherapeutics of visceral leishmaniasis: present and future developments.

Authors:  Shyam Sundar; Anup Singh
Journal:  Parasitology       Date:  2017-12-07       Impact factor: 3.234

8.  Water-soluble polymer-drug conjugates for combination chemotherapy against visceral leishmaniasis.

Authors:  Salvatore Nicoletti; Karin Seifert; Ian H Gilbert
Journal:  Bioorg Med Chem       Date:  2010-03-02       Impact factor: 3.641

Review 9.  Control of visceral leishmaniasis in latin america-a systematic review.

Authors:  Gustavo A S Romero; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2010-01-19

10.  Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.

Authors:  Dinesh Mondal; Shri Prakash Singh; Narendra Kumar; Anand Joshi; Shyam Sundar; Pradeep Das; Hirve Siddhivinayak; Axel Kroeger; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2009-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.